VSEE HEALTH, INC. (VSEE) VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care environments, including neurointensive, cardiac intensive, and general intensive care units (ICUs). This system addresses complex conditions such as stroke, spinal cord injuries, brain trauma, and other severe neurological disorders. Beyond specialized care, their broader telehealth platform provides a modular suite of digital tools, empowering clients to customize solutions to their unique needs. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Sector: Services-Health Services
Industry: Medical - Healthcare Information Services
VSee Health, Inc. OTC:VSEE OTC (suspended from Nasdaq on Aug 6, 2026) Healthcare · Medical - Healthcare Information Services
Mkt Cap $185K
EV -
SI 1.3%
Net Cash/Sh -
Prev close $0.2469 -11.41%Open $0.2187 +5.17%Now $0.2300 VOL 55K $ Vol $11K RVOL 2.19x
Mkt Cap $185K
EV -
VOL 55K sh
$ Vol $11K
RVOL 2.19×
SI 1.3%
Net Cash/Sh -
Press Release
VSee Health Announces 13 New Hospital Agreements Expected to Generate More Than $3 Million in Annual Revenue
VSee Health's subsidiary iDoc signed multi-year agreements covering 13 new hospitals for tele-ICU and teleradiology services. The contracts are expected to add more than $3 million in annual recurring revenue, consolidated into VSee Health's results.
• 12d ago AI analysis › Press Release
VSee Health Shareholder Letter
VSee Health CEO Dr. Imoigele Aisiku issued a shareholder letter confirming the company's NASDAQ delisting and describing a strategic refocus on iDoc, its hospital-focused telehealth business. The letter cites growth into 58 hospitals and says revenue from continuing operations grew in the first half of 2026, though no specific figures are disclosed.
• 26d ago AI analysis › Press Release ● Major
VSee Health Poised for Growth
VSee Health announced the results of its annual meeting, approving an 80:1 reverse stock split as it transitions off the Nasdaq. Management identified approximately $1 million in annual savings from reduced public-company expenses and intends to redirect funds toward growth.
• 2mo ago AI analysis › Press Release ● Major
VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings
VSee Health signed a non-binding letter of intent to acquire a healthcare commerce platform valued at $42 million, which includes assets generating over $35 million in annual revenue and approximately $7 million in EBITDA. The transaction is expected to close quickly without initial shareholder dilution, pending the completion of due diligence and the negotiation of definitive agreements.
• 3mo ago AI analysis › Press Release ● Major
VSEE Vertically Integrated Healthcare Commerce Platform
VSee Health signed a non-binding letter of intent to acquire healthcare technology and operating assets valued at $42 million. The target assets currently generate an annual run rate of over $35 million and approximately $7 million in EBITDA, which would complement VSee's existing API-driven virtual care platform.
• 3mo ago AI analysis › Press Release
VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value
VSee Health's board has initiated a comprehensive strategic review to evaluate transformational opportunities, citing active late-stage discussions with potential strategic partners. The review aims to maximize shareholder value through alternatives including mergers, acquisitions, licensing, and capital formation, driven by a belief that current valuation does not reflect the company's strength.
• 3mo ago AI analysis › Press Release ● Major
VSee Health Reaffirms Commitment to Minimizing Shareholder Dilution
VSee Health's board approved a proposed maximum 80-for-1 reverse stock split, reduced from a previously proposed 250-for-1, to satisfy Nasdaq continued listing requirements. The company terminated its previously announced standby equity purchase agreement and confirmed it has no active equity financing facilities expected to cause near-term dilution.
• 3mo ago AI analysis › Press Release
VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations
VSee Health outlined its strategy to integrate AI into its telehealth infrastructure, positioning the platform as an operating layer for hospital systems. The company reported substantial operational momentum, growing its hospital network from 3 in 2024 to 58 in 2026, with all revenue now derived from its iDoc platform.
• 4mo ago AI analysis › Press Release
VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations
VSee Health expanded its hospital footprint 20-fold to 58 locations over the past two years, establishing a major inflection point in its enterprise telehealth strategy. This network expansion drove an 80% increase in revenue during 2025, bringing total revenue to $11.4 million.
• 4mo ago AI analysis › Press Release
VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale
VSee Health provided a business update following the May 31 sale of VSee Lab, reporting pro-forma revenue growth of 60% to $8 million in 2025 and 70% to $2.5 million in Q1 2026. The company expects to reduce annual operating expenses by approximately $6.0 million as it refocuses on its iDoc telehealth platform and enterprise solutions.
• 4mo ago AI analysis › Press Release ● Major
VSee Health Completes Strategic Separation of VSee Lab, Retires Approximately 7% of Outstanding Shares, and Transitions to Single CEO Leadership
VSee Health completed the sale of its VSee Lab subsidiary to former Co-CEO Milton Chen, who in turn returned 2,870,069 shares of VSee stock to the company for retirement. The retired shares represent approximately 7% of outstanding common stock, effectively reducing dilution and simplifying the capital structure. Concurrently, Milton Chen resigned as Co-CEO and Chairman, with Dr.
• 5mo ago AI analysis › 1 law-firm class-action alert